Skip to main content
SEEGENE, INC. logo

SEEGENE, INC. — Investor Relations & Filings

Ticker · 096530 ISIN · KR7096530001 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2023-03-07 Notice of Dividend Amou…
Country KR South Korea
Listing KO 096530

About SEEGENE, INC.

https://www.seegene.com/

Seegene, Inc. is a company specializing in molecular diagnostics. It develops and manufactures in vitro diagnostic (IVD) products and automated systems based on its proprietary multiplex real-time PCR technologies. These technologies enable the simultaneous detection of multiple pathogens from a single sample, facilitating a syndromic testing approach for various conditions. The company's portfolio includes a broad range of diagnostic assays for infectious diseases, including respiratory illnesses, sexually transmitted infections (STIs), and human papillomavirus (HPV). Seegene also provides automated platforms, such as its All-in-One systems, to streamline laboratory workflows. The company engages in technology-sharing initiatives and strategic collaborations to advance the standardization and accessibility of molecular diagnostics globally.

Recent filings

Filing Released Lang Actions
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Seegene regarding the determination of a record date for quarterly dividend eligibility. It specifies the record date (2023-03-31) and the purpose (confirming shareholders for dividends). While it relates to dividends, it is not the final declaration of the dividend amount (which the text explicitly states will be decided later), but rather a procedural notice regarding shareholder record-keeping for dividend purposes. Given the nature of the announcement as a regulatory disclosure of corporate action, it fits best under the 'Notice of Dividend Amount' category as it pertains to the dividend process.
2023-03-07 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Seegene. It contains the meeting agenda, voting procedures, electronic voting information, and management reference materials (such as board activity and business overview). This type of document is standard for proxy solicitation and providing shareholders with the necessary information to vote at an upcoming meeting, which falls under the Proxy Solicitation & Information Statement category.
2023-03-07 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic/proxy), and management's explanation of business performance (MDA section). While it contains management discussion, the primary regulatory purpose of this specific filing is to solicit proxies for the AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-07 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding a decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a corporate action involving the company buying back its own shares through a trust. According to the provided definitions, 'Transaction in Own Shares' (POS) is the correct category for reports of a company buying back or selling its own shares.
2023-02-28 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Seegene, detailing quarterly and cumulative financial performance metrics such as revenue, operating profit, and net income. It provides key financial highlights rather than a full annual report. According to the filing definitions, an initial announcement of quarterly/periodical financial results is classified as an Earnings Release (ER). Q4 2022
2023-02-17 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a significant change in financial performance (revenue/profit fluctuation of over 30%). It provides preliminary financial results (revenue, operating profit, net income) for the fiscal year compared to the previous year. This is a standard 'Earnings Release' (ER) format used in the Korean market to announce preliminary financial results before the final audited annual report is published. FY 2022
2023-02-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.